Gj. Grover et al., THE K-ATP BLOCKER SODIUM 5-HYDROXYDECANOATE DOES NOT ABOLISH PRECONDITIONING IN ISOLATED RAT HEARTS, European journal of pharmacology, 277(2-3), 1995, pp. 271-274
Blockers of ATP-sensitive K+ channels (K-ATP) abolish preconditioning
in several species. Glyburide does not abolish preconditioning in rat
hearts, but this may be due to a loss of its activity during ischemia.
We determined the effect of a K-ATP blocker, which is more active dur
ing ischemia (sodium 5-hydroxydecanoate, 5-HD), on preconditioning in
isolated rat hearts. Rat hearts were subjected to 4 periods of 5 min g
lobal ischemia followed by 30 min of global ischemia and reperfusion.
Preconditioning significantly enhanced post-ischemic recovery of funct
ion and reduced lactate dehydrogenase (LDH) release vs. sham. 5-HD (10
0 mu M) did not abolish preconditioning. Cromakalim (20 mu M) was prot
ective in this ischemic model and this was abolished by 5-HD. This is
further evidence that K-ATP opening is not the mechanism of preconditi
oning in rats.